Vycor Medical Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,089.40
1,250.30
1,138.60
1,452.70
1,385.00
1,509.30
Cost of Goods Sold (COGS) incl. D&A
504.40
524.90
524.50
442.30
502.60
336
Gross Income
585.00
725.40
614.20
1,010.40
882.40
1,173.30
SG&A Expense
2,866.50
3,457.50
2,605.20
2,601.80
2,195.00
2,183.50
EBIT
2,281.50
2,732.20
1,991.00
1,591.40
1,312.60
1,010.20
Unusual Expense
-
1,081.20
19.80
-
-
307.60
Non Operating Income/Expense
-
105.70
63.70
0.10
115.30
1.40
Interest Expense
191.30
130.70
47.70
61.00
49.20
60.20
Pretax Income
2,472.80
4,049.70
2,082.60
1,652.30
1,477.00
1,379.40
Consolidated Net Income
2,472.80
4,049.70
2,082.60
1,652.30
1,477.00
1,379.40
Net Income
2,472.80
4,049.70
2,082.60
1,652.30
1,477.00
1,379.40
Net Income After Extraordinaries
2,472.80
4,049.70
2,082.60
1,652.30
1,477.00
1,379.40
Net Income Available to Common
2,472.80
4,049.70
2,250.40
1,832.00
1,801.40
1,703.70
EPS (Basic)
0.39
0.54
0.21
0.17
0.10
0.08
Basic Shares Outstanding
6,324.20
7,559.40
10,839.30
11,066.20
18,373.40
21,599.10
EPS (Diluted)
0.39
0.54
0.21
0.17
0.10
0.08
Diluted Shares Outstanding
6,324.20
7,559.40
10,839.30
11,066.20
18,373.40
21,599.10
EBITDA
1,905.30
2,349.20
1,622.10
1,323.90
1,022.60
832.80
Preferred Dividends
-
-
167.80
179.70
324.40
324.40
About Vycor Medical
View Profile
